Skip to main content
Signal8

Rapid Therapeutic Science Laboratories, Inc. (RTSL)

Sector: Medical - Pharmaceuticals

Industry: Medical - Pharmaceuticals

Rapid Therapeutic Science Laboratories, Inc. logo

Rapid Therapeutic Science Laboratories, Inc.

OTC:RTSLHealthcare
$0.0001
CLOSED
Mkt Cap$883
EV-
Float3.69M
O/S8.83M
VOL213 sh
$ Vol$0
RVOL0.41×
Inst Own-
Net Cash/Sh-
Dilution
Historical Data
DateOpenHighLowCloseVolume
Nov 13, 20260.00010.00010.00010.0001213
Nov 12, 20260.00010.00030.00010.0003832
Analyst Coverage
No analyst coverage for this companyNo ratings, price targets, or covering firms on file.
About

Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a biotechnology firm specializing in the aerosolized delivery of non-psychoactive cannabinoids directly into the bloodstream. This innovative approach is aimed at treating various conditions, including chronic pain, post-traumatic stress disorder (PTSD), insomnia, and aiding in surgery recovery, among other health issues. RTSL's product portfolio features pressurized meter dose inhalers (MDIs), designed to precisely dispense an aerosolized mist into the lungs, alongside sublingual oral spray devices. Furthermore, the company offers water-soluble cannabidiol (CBD) and cannabigerol (CBG) isolates under its "nhaler" brand. Established in 2013 and based in Dallas, Texas, the company adopted its current name, Rapid Therapeutic Science Laboratories, Inc., in January 2020, having previously operated as Holly Brothers Pictures, Inc.

It was also formerly a subsidiary of Texas Mdi, Inc.

Key Metrics
Market Cap$883
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 8.83M shares outstanding

SectorHealthcare
IndustryMedical - Pharmaceuticals
ExchangeOTC
CountryUSUS
IPO DateJun 14, 2017
Shares Outstanding8.83M
Authorized Shares
Float3.69M
52-Week Range
$0.0001$0.0070
$0.0001(0th percentile)
Volume
Average Daily Volume523
213 today vs 523 avg(-59%)

30d Avg

523

60d Avg

523

90d Avg

432

Earnings
Dividend History
No dividend history available

Rapid Therapeutic Science Laboratories, Inc. (OTC: RTSL) traded at $0.0001 on Nov 13, 2026. 52-week range: $0.0001 to $0.0070. The company is in the Healthcare sector (Medical - Pharmaceuticals).